Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GAREM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506990 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGPAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDM1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGPS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YPEL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM185A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP140L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC37A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C18orf25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ICMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on